ArticleJornal brasileiro de nefrologia

Real-world cost-effectiveness analysis of thymoglobulin versus no induction therapy in kidney transplant recipients at low risk of graft loss.

Adrieli Barros Bessa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.